Dormant
CACI · CACI INTERNATIONAL CLA
Last analysed ·
Current thesis
CACI International's defense-technology re-rating requires a weekly recovery above $646 and reaffirmed fiscal 2027 guidance at the next results. A weekly close below $600 would invalidate the recovery case.
Kill line
A weekly close below $600 invalidates the recovery case; $600 is a round-number research boundary. A reduction in the August 5 fiscal 2027 revenue guide of $10.65–10.85 billion or withdrawal of the at-least-$900 million free-cash-flow outlook would separately break the operating case.
Pick status
Open commitment catalyst in 25dscored if the kill line above fires How this is scored →Latest analysis and events for CACI —
As of 19 September 2026, the latest FrontierPicks analysis for CACI INTERNATIONAL CLA (CACI): CACI International's defense-technology re-rating requires a weekly recovery above $646 and reaffirmed fiscal 2027 guidance at the next results. A weekly close below $600 would invalidate the recovery case.
Kill line: A weekly close below $600 invalidates the recovery case; $600 is a round-number research boundary. A reduction in the August 5 fiscal 2027 revenue guide of $10.65–10.85 billion or withdrawal of the at-least-$900 million free-cash-flow outlook would separately break the operating case.
Next dated event on file: — catalyst in 25d.
Current Thesis
CACI International's defense-technology re-rating requires a weekly recovery above the former $646 shelf and reaffirmed fiscal 2027 guidance at the next results; a weekly close below $600 would invalidate that recovery case. The operating foundation remains the August 5, 2026 guidance for revenue of $10.65–10.85 billion and free cash flow of at least $900 million, attributed to CACI's fiscal 2026 results release.
Since the September 5 note, CACI has announced a September 16 Central Command award, while Investing.com reported on September 10 that Truist reiterated its $800 analyst target after management meetings. The narrative is maturing — those September developments extend the established defense-technology story, but the September 18 reference close of $626.85 remains below the former $646 shelf. This is an inference about the narrative's stage, not a measurement of investor participation. CACI announcements, September 10 Truist coverage.
Bullish and bearish views on CACI INTERNATIONAL CLA
The model's bull view on CACI INTERNATIONAL CLA (CACI), in brief: Cash generation supports the transition. The bear view: Backlog growth remains modest overall. CACI's August 5, 2026 results put total backlog at $32.0 billion, up 2% year over year, with a book-to-bill ratio of 1.1 times, meaning awards relative to revenue. A subsequent ratio below 1.0 times would show awards failing to replace… Both cases follow in full.
Bull Case
- Cash generation supports the transition. CACI reported fiscal 2026 free cash flow of $735.4 million, up 66.2% year over year, on August 5, 2026, alongside fiscal 2027 guidance of at least $900 million. Those figures establish cash conversion as a measurable test of the expansion story.
- Funded demand provides operating evidence. The August 5, 2026 results reported funded backlog growth of 29% year over year and fiscal 2026 organic revenue growth of 7.2%. These company figures support the operating case independently of analyst targets.
- September brings another contract announcement. CACI's September 16, 2026 announcement describes an award supporting Central Command's information advantage and irregular warfare operations, with one year plus four option periods. The announcement extends the contract record; it does not establish how much revenue will fall into fiscal 2027. CACI announcement listing.
Bear Case
- Backlog growth remains modest overall. CACI's August 5, 2026 results put total backlog at $32.0 billion, up 2% year over year, with a book-to-bill ratio of 1.1 times, meaning awards relative to revenue. A subsequent ratio below 1.0 times would show awards failing to replace recognized revenue.
- Analyst updates point different ways. Argus's September 9, 2026 report lowered its target to $688; September 10 coverage reported Truist reiterating $800. These are attributed analyst opinions, and neither update establishes a company guidance increase. Argus report, Truist coverage.
- Contract ceilings overstate committed revenue. The August 17–18, 2026 NITE-STAR announcements described a $981 million indefinite-delivery, indefinite-quantity contract shared across 15 awardees. That ceiling cannot be treated as CACI revenue or as a CACI-specific backlog addition.
Setup & Price Structure
The September 18, 2026 adjusted daily close was $626.85, compared with $623.61 on September 4. The 14-day relative strength index (RSI) improved to 49.5 from 41.0 over those observations. This establishes improvement between the dated readings; the sample is too small to establish a durable reversal.
As of September 18, the shares had risen 39.4% over three months and stood 7.8% below the supplied 52-week high of $680.08. The former approximately $646 post-results shelf remains unrecovered. A weekly close above $646 would satisfy the price component of the recovery case; the $600 invalidation boundary remains a round-number research condition rather than demonstrated chart support.
Retrospective investment-return articles appeared on September 11 and September 18, 2026. Their repeated format is observable coverage clustering, but this small sample does not establish retail crowding. The price and headline observations do not measure short interest, ownership concentration or distance above a rising moving average.
Catalyst Calendar (next 30 days)
- 2026-09-30 — Federal fiscal year-end. This is also the end of CACI's first fiscal 2027 quarter. The August 5 revenue guidance of $10.65–10.85 billion provides the operating benchmark, but quarter-end itself is not an earnings release or a scheduled contract award.
- 2026-10-15 — Shareholder meeting. CACI's investor calendar lists the meeting at 9:30 a.m. Eastern time. It supplies a confirmed company event within the next 30 days; the listing does not promise a guidance update. CACI investor calendar.
- ~2026-10-21, est. First-quarter fiscal 2027 results. This later event remains the substantive operating test. The date is unconfirmed; the prior-year release occurred on October 22, 2025. Reaffirmation of the August 5 revenue and free-cash-flow guidance would satisfy the operating component of the recovery case. Prior-year release.
What Would Change Our Mind
Failure of the remaining recovery structure would end the case: a weekly close below $600 is the published price invalidation. A fiscal 2027 revenue-guidance reduction below the August 5 range of $10.65–10.85 billion, or withdrawal of the at-least-$900 million free-cash-flow outlook, would separately undermine the operating argument.
For the thesis to play out, CACI must record a weekly close above $646 and retain those guidance commitments at its next quarterly results before the price invalidation occurs. The September 18 close of $626.85 has not met the price requirement.
Correlation Notes
This remains a single-name setup: CACI's September 16 Central Command award and August 17 Space Force selection establish exposure to federal defense demand, but do not demonstrate a shared price trend across defense companies. Appropriations and award timing are therefore plausible common drivers, an inference from the named customers. No dated peer-return sample supports a numerical correlation claim or a conclusion that a sector move will carry CACI above its former shelf.
Notes
- Fiscal year ends June 30 — 'FY2027' covers July 2026 to June 2027, so guidance never lines up with calendar-year comparisons.
- Adjusted EPS excludes acquisition intangible amortization; the FY2027 GAAP guide is $25.74–26.64 versus adjusted $32.96–33.86.
- Multiple-award IDIQ headlines (NITE-STAR $981M, SkyValor $500M) are ceilings shared across an awardee pool; revenue arrives only through task orders.
- Pro-forma leverage was 3.7x at FY2026 year-end after the ARKA Group acquisition, so the name carries more credit sensitivity than debt-light services peers.
- Revenue is concentrated in US federal contracts; appropriations timing shifts award flow between quarters independent of execution.
Related · shared themes
MRCY
Mercury Systems Inc
Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print. Consolidation, not acceleration — the move is maturing into the report.
DPRO
Draganfly Inc.
Draganfly's policy-led drone re-rating now has a Canadian defence contract behind it, announced on 2026-09-11. A weekly close above the historical $6.23 reference would confirm price recovery; a weekly close below $4.70 would invalidate the case.
ATI
ATI Inc.
Titanium/superalloy aero-defense supplier digesting a June breakout above the reclaimed $183.30 ATH shelf: ~9% off the $204.09 high, RSI cooled to ~66, consensus PT $200.33 back above spot. Q2 lands 2026-08-06; peer CRS prints 2026-07-30 as a free read-through. maturing theme — the clean setup is a base or the post-print, not a chase into the binary.
ALM
Almonty Industries Inc.
Non-China tungsten narrative now trades on one venue: the TSX exit took effect 2026-07-31 and the ASX removal 2026-09-01, leaving Nasdaq and Frankfurt. The operating case is unchanged — Sangdong throughput since 2026-07-01, Q2 revenue C$43.0M (+498%) on APT at US$3,075/MTU — but August APT slipped to US$2,900–3,000/mtu and the shares sit 25.0% under $23.42, a maturing narrative with no company-dated catalyst before the ~2026-11-12 print.